Malaria, Malaria in Pregnancy, Placental Malaria
Conditions
Keywords
malaria, pregnancy, placental malaria, malaria in pregnancy, birth weight, anemia
Brief summary
This study seeks to determine whether screening pregnant women for malaria with malaria rapid diagnostic tests (RDTs) may detect placental infection and predict risk of poor birth outcomes due to malaria in areas of varied malaria transmission in Africa.
Detailed description
Malaria prevention measures for pregnant women are critical and available, but the effectiveness of intermittent preventive treatment (IPTp) with sulfadoxine-pyrimethamine, a cornerstone in this prevention effort, is declining with increasing parasite resistance. New drugs for IPTp are being considered, but there are disadvantages to presumptive use of the few remaining efficacious antimalarials. An alternative approach may involve screening with diagnostic tests to better target efficacious antimalarial treatment to asymptomatic women with laboratory evidence of malaria infection. Light microscopy of peripheral maternal blood misses a large proportion of cases, and PCR is unavailable in routine health care settings. Preliminary evidence suggests that detection of parasite antigen in peripheral blood may provide an accurate indicator of clinically significant infections and predict pregnancy outcomes. Therefore, screening with RDTs may offer an accurate and practical way to identify pregnant women who will benefit from targeted therapy for placental malaria infection. Antigen detection thresholds vary widely among RDTs, and the distribution of target antigens in peripheral blood circulation is expected to differ; therefore, the potential value of RDTs in this population can best be established by evaluating the detection of placental parasitemia for highly-characterized RDTs, enabling results to be extrapolated to other products and programs. The study described here is proposed to address this question.
Interventions
None listed
Sponsors
Foundation for Innovative New Diagnostics, Switzerland
UNICEF
World Bank
World Health Organization
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
16 Years to 44 Years
Healthy volunteers
No
Inclusion criteria
Specific participant selection criteria include: 1. Presenting for care after quickening and before onset of labor (i.e. in the second or third trimester of pregnancy) 2. Age between 16 years and 44 years, inclusive 3. Willingness and ability to follow up with study visits and activities through the duration of pregnancy and at delivery 4. Absence of history of serious adverse reaction to sulfa drugs 5. Absence of history of serious adverse reaction to artemisinin-based drugs (depending on national policy on treatment of malaria in pregnancy) 6. Absence of HIV infection (both because guidelines for malaria prevention in pregnancy for HIV-infected women differ from those for HIV-negative women, and in order to avoid confounding of pregnancy outcomes by HIV-related complications or treatments in this early evaluation) 7. Absence of history of or current obstetrical complications (e.g. pre-eclampsia, eclampsia, hypertension during pregnancy, post-partum hemorrhage, evidence of multiple gestation) 8. Absence of chronic disease (e.g. diabetes mellitus, sickle cell disease) 9. Absence of evidence of severe acute disease requiring inpatient management or referral 10. Provision of written informed consent 11. Enrollment Hb ≥7 g/dL
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| accuracy of diagnostic tests during gestation | 2nd trimester of pregnancy | accuracy of malaria RDTs, blood smears and PCR performed on maternal peripheral blood to diagnose or predict placental malaria during gestation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| association of placental malaria with infant birth weight | at birth | — |
| association of placental malaria with maternal hemoglobin | twice during gestation and at delivery | — |
| accuracy of diagnostic tests at delivery | at delivery | accuracy of malaria RDTs, peripheral blood smears and PCR performed on maternal peripheral blood to diagnose placental malaria at delivery |
Countries
Burkina Faso, Uganda
Contacts
PRINCIPAL_INVESTIGATORHeidi A Hopkins, MD
Foundation for Innovative New Diagnostics, Kampala, Uganda
PRINCIPAL_INVESTIGATORJean-Bosco Ouedraogo, MD, PhD
IRSS, Direction Regionale de l'Ouest, Bobo-Dioulasso, Burkina Faso
STUDY_DIRECTORDavid Bell, MBBS, PhD
Foundation for Innovative New Diagnostics, Geneva, Switzerland
STUDY_DIRECTORJane Cunningham, MD
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland
PRINCIPAL_INVESTIGATORMiriam Nakalembe, MBChB
Makerere University Faculty of Medicine, Kampala, Uganda
Outcome results
None listed